Literature DB >> 25720504

TAPBPR: a new player in the MHC class I presentation pathway.

C Hermann1, J Trowsdale, L H Boyle.   

Abstract

In order to provide specificity for T cell responses against pathogens and tumours, major histocompatibility complex (MHC) class I molecules present high-affinity peptides at the cell surface to T cells. A key player for peptide loading is the MHC class I-dedicated chaperone tapasin. Recently we discovered a second MHC class I-dedicated chaperone, the tapasin-related protein TAPBPR. Here, we review the major steps in the MHC class I pathway and the TAPBPR data. We discuss the potential function of TAPBPR in the MHC class I pathway and the involvement of this previously uncharacterised protein in human health and disease.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  TAPBPR/TAPBPL; antigen processing and presentation; disease association; human; major histocompatibility complex (MHC); tapasin

Mesh:

Substances:

Year:  2015        PMID: 25720504     DOI: 10.1111/tan.12538

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  14 in total

1.  Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing.

Authors:  Giora I Morozov; Huaying Zhao; Michael G Mage; Lisa F Boyd; Jiansheng Jiang; Michael A Dolan; Ramesh Venna; Michael A Norcross; Curtis P McMurtrey; William Hildebrand; Peter Schuck; Kannan Natarajan; David H Margulies
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-11       Impact factor: 11.205

2.  Production of soluble pMHC-I molecules in mammalian cells using the molecular chaperone TAPBPR.

Authors:  Sara M O'Rourke; Giora I Morozov; Jacob T Roberts; Adam W Barb; Nikolaos G Sgourakis
Journal:  Protein Eng Des Sel       Date:  2019-12-31       Impact factor: 1.650

3.  Single-Molecule RNA Sequencing Reveals IFNγ-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus-Positive MCC Cell Lines.

Authors:  Tatjana Sauerer; Christopher Lischer; Adrian Weich; Carola Berking; Julio Vera; Jan Dörrie
Journal:  Front Microbiol       Date:  2021-12-22       Impact factor: 5.640

Review 4.  Spotlight on TAP and its vital role in antigen presentation and cross-presentation.

Authors:  Ian Mantel; Barzan A Sadiq; J Magarian Blander
Journal:  Mol Immunol       Date:  2021-12-29       Impact factor: 4.174

5.  Identification of TAPBPL as a novel negative regulator of T-cell function.

Authors:  Yujun Lin; Cheng Cui; Min Su; Lawrence K Silbart; Haiyan Liu; Jin Zhao; Lang He; Yuanmao Huang; Dexin Xu; Xiaodan Wei; Qian Du; Laijun Lai
Journal:  EMBO Mol Med       Date:  2021-05-03       Impact factor: 12.137

6.  TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap.

Authors:  Andrew C McShan; Christine A Devlin; Giora I Morozov; Sarah A Overall; Danai Moschidi; Neha Akella; Erik Procko; Nikolaos G Sgourakis
Journal:  Nat Commun       Date:  2021-05-26       Impact factor: 14.919

7.  TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst.

Authors:  Clemens Hermann; Andy van Hateren; Nico Trautwein; Andreas Neerincx; Patrick J Duriez; Stefan Stevanović; John Trowsdale; Janet E Deane; Tim Elliott; Louise H Boyle
Journal:  Elife       Date:  2015-10-06       Impact factor: 8.140

Review 8.  Proofreading of Peptide-MHC Complexes through Dynamic Multivalent Interactions.

Authors:  Christoph Thomas; Robert Tampé
Journal:  Front Immunol       Date:  2017-02-08       Impact factor: 7.561

9.  Interferon γ induced compositional changes in human bone marrow derived mesenchymal stem/stromal cells.

Authors:  Qingdong Guan; Peyman Ezzati; Victor Spicer; Oleg Krokhin; Donna Wall; John A Wilkins
Journal:  Clin Proteomics       Date:  2017-07-06       Impact factor: 3.988

10.  Whole genome duplications have provided teleosts with many roads to peptide loaded MHC class I molecules.

Authors:  Unni Grimholt
Journal:  BMC Evol Biol       Date:  2018-02-23       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.